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The American College of Cardiology Foundation (ACCF) and The Society of Thoracic Surgeons (STS) are embarking on a unique partnership to study 
comparative effectiveness of percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG) surgery for the treatment of stable 
coronary artery disease. The primary endpoint is all-cause mortality during follow-up of five years. Cost-effectiveness analysis will also be performed. 
The cohorts will be patients treated with drug eluting or bare metal stents or with CABG. Among 100,681 isolated CABG operations in the STS 
Database, 30,459 (30%) had at least one matched diagnostic catheterization procedure in the ACCF Database. For these patients, angiographic 
data were highly complete with fewer than 8% missing variables. Both Databases are being probabilistically linked to the Centers for Medicare and 
Medicaid Services data to provide long-term outcomes. A subset of 2,000 patients will be evaluated for SYNTAX score. In preliminary tabulations, 
approximately 101,000 isolated CABG operations and 186,000 PCI procedures were performed on patients meeting our proposed eligibility criteria 
during 2004-2006 at 528 hospitals. After including Centers for Medicare and Medicaid Services data for 2007, we anticipate approximately 
102,000 more patients. In an analysis of linked Centers for Medicare and Medicaid Services data with a median follow-up of 562 days for eligible 
CABG patients and median 507 days for eligible PCI patients, 8,350 deaths were captured in Centers for Medicare and Medicaid Services for CABG 
patients and 13,235 deaths were captured for PCI patients. Kaplan-Meier estimated probabilities of mortality at 12 months were 6.76% (95% CI: 
6.59% - 6.92%) for CABG patients and 6.05% (95% CI: 5.93% - 6.18%) for PCI patients. This study will permit extensive assessment of long-term 
clinical and economic outcomes after coronary revascularization.
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